 Low-dose dapsone prophylaxis Pneumocystis carinii pneumonia AIDS AIDS-related complex efficacy toxicity cost dapsone mg/day prophylaxis Pneumocystis carinii pneumonia PCP patients AIDS AIDS-related complex ARC patients primary secondary prophylaxis patients maximum dose mg/day maximum mg/day median duration weeks patients prophylaxis May patients none pneumocystis infection patient AIDS mild relapse mg/day Hematologic toxicity mild therapy rash due patients review patients institution history PCP prophylaxis relapses fatal Cost analysis significant advantage oral dapsone aerosolized pentamidine